The global market for GLP-1 receptor agonists shows a surge in demand due to their effectiveness in managing type 2 diabetes. Several pharmaceutical companies have received FDA approval to develop these life-changing medications. {Novo Nordisk|Ascensia Pharmaare a leading producer of GLP-1 receptor agonists, with well-established products like